KeyBanc cuts Carpenter Technology to sector weight from overweight
CRS•KeyBanc cut its rating on Carpenter Technology to sector weight from overweight.
Related News
Wintrust Financial Corporation: Truist Securities cuts target price to $175 from $183
WTFC•
Enanta doses first patient in Phase 2b/3 trial of RSV drug zelicapavir
ENTA•
Disc Medicine target price raised to $130 from $100
IRON•
Obesity drug developer Corxel to go public in US via SPAC deal
AMAN•
Acumen Pharmaceuticals Q3 2026 net loss narrows year over year to $25.37 million
ABOS•